Evaluation of [18F]MNI-1126 as an Imaging Marker for Synaptic Density Loss

Clinical trial NCT03587649 · COMPLETED

Trial details

NCT number: NCT03587649
Sponsor: Invicro
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Alzheimer Disease Parkinson Disease Healthy Volunteers

Start date: 2018-05-07
Primary completion: 2020-02-26
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.